ProCE Banner Activity

Frequently Asked Questions About CAR T-Cell Therapy

Clinical Thought
Read expert answers to audience questions from a recent symposium on current best practices and emerging directions in CAR T-cell therapy.

Released: March 24, 2020

Expiration: March 23, 2021

Share

Faculty

Jae H. Park

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Celgene

Kite A GILEAD Company

Faculty Disclosure

Primary Author

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Jae Park, MD, has disclosed that he has received consulting fees from Amgen, Allogene, AstraZeneca, Autolus, GlaxoSmithKline, Kite Pharma, Novartis, and Takeda.